Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 298

1.

Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis.

Wlodarska M, Willing B, Keeney KM, Menendez A, Bergstrom KS, Gill N, Russell SL, Vallance BA, Finlay BB.

Infect Immun. 2011 Apr;79(4):1536-45. doi: 10.1128/IAI.01104-10. Epub 2011 Feb 14.

3.

Citrobacter rodentium-induced colitis: A robust model to study mucosal immune responses in the gut.

Koroleva EP, Halperin S, Gubernatorova EO, Macho-Fernandez E, Spencer CM, Tumanov AV.

J Immunol Methods. 2015 Jun;421:61-72. doi: 10.1016/j.jim.2015.02.003. Epub 2015 Feb 19.

PMID:
25702536
4.

Dietary vitamin D3 deficiency alters intestinal mucosal defense and increases susceptibility to Citrobacter rodentium-induced colitis.

Ryz NR, Lochner A, Bhullar K, Ma C, Huang T, Bhinder G, Bosman E, Wu X, Innis SM, Jacobson K, Vallance BA.

Am J Physiol Gastrointest Liver Physiol. 2015 Nov 1;309(9):G730-42. doi: 10.1152/ajpgi.00006.2015. Epub 2015 Sep 3.

5.

The lymphotoxin-beta receptor is critical for control of murine Citrobacter rodentium-induced colitis.

Spahn TW, Maaser C, Eckmann L, Heidemann J, L├╝gering A, Newberry R, Domschke W, Herbst H, Kucharzik T.

Gastroenterology. 2004 Nov;127(5):1463-73.

PMID:
15521015
6.

Lyn deficiency leads to increased microbiota-dependent intestinal inflammation and susceptibility to enteric pathogens.

Roberts ME, Bishop JL, Fan X, Beer JL, Kum WW, Krebs DL, Huang M, Gill N, Priatel JJ, Finlay BB, Harder KW.

J Immunol. 2014 Nov 15;193(10):5249-63. doi: 10.4049/jimmunol.1302832. Epub 2014 Oct 22.

7.

Citrobacter rodentium: infection, inflammation and the microbiota.

Collins JW, Keeney KM, Crepin VF, Rathinam VA, Fitzgerald KA, Finlay BB, Frankel G.

Nat Rev Microbiol. 2014 Sep;12(9):612-23. doi: 10.1038/nrmicro3315. Epub 2014 Aug 4. Review.

PMID:
25088150
8.

Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa.

Bergstrom KS, Kissoon-Singh V, Gibson DL, Ma C, Montero M, Sham HP, Ryz N, Huang T, Velcich A, Finlay BB, Chadee K, Vallance BA.

PLoS Pathog. 2010 May 13;6(5):e1000902. doi: 10.1371/journal.ppat.1000902.

9.

Autophagy in the intestinal epithelium regulates Citrobacter rodentium infection.

Inoue J, Nishiumi S, Fujishima Y, Masuda A, Shiomi H, Yamamoto K, Nishida M, Azuma T, Yoshida M.

Arch Biochem Biophys. 2012 May;521(1-2):95-101. doi: 10.1016/j.abb.2012.03.019. Epub 2012 Mar 27.

PMID:
22475450
10.

The Mouse Model of Infection with Citrobacter rodentium.

Bouladoux N, Harrison OJ, Belkaid Y.

Curr Protoc Immunol. 2017 Nov 1;119:19.15.1-19.15.25. doi: 10.1002/cpim.34.

PMID:
29091261
11.

Intestinal epithelium-specific MyD88 signaling impacts host susceptibility to infectious colitis by promoting protective goblet cell and antimicrobial responses.

Bhinder G, Stahl M, Sham HP, Crowley SM, Morampudi V, Dalwadi U, Ma C, Jacobson K, Vallance BA.

Infect Immun. 2014 Sep;82(9):3753-63. doi: 10.1128/IAI.02045-14. Epub 2014 Jun 23.

12.

Social stress-enhanced severity of Citrobacter rodentium-induced colitis is CCL2-dependent and attenuated by probiotic Lactobacillus reuteri.

Mackos AR, Galley JD, Eubank TD, Easterling RS, Parry NM, Fox JG, Lyte M, Bailey MT.

Mucosal Immunol. 2016 Mar;9(2):515-26. doi: 10.1038/mi.2015.81. Epub 2015 Sep 30.

13.

Colonic microbiota alters host susceptibility to infectious colitis by modulating inflammation, redox status, and ion transporter gene expression.

Ghosh S, Dai C, Brown K, Rajendiran E, Makarenko S, Baker J, Ma C, Halder S, Montero M, Ionescu VA, Klegeris A, Vallance BA, Gibson DL.

Am J Physiol Gastrointest Liver Physiol. 2011 Jul;301(1):G39-49. doi: 10.1152/ajpgi.00509.2010. Epub 2011 Mar 31.

14.

Citrobacter rodentium infection causes iNOS-independent intestinal epithelial dysfunction in mice.

Skinn AC, Vergnolle N, Zamuner SR, Wallace JL, Cellars L, MacNaughton WK, Sherman PM.

Can J Physiol Pharmacol. 2006 Dec;84(12):1301-12.

PMID:
17487239
15.

CD4+ T cells drive goblet cell depletion during Citrobacter rodentium infection.

Chan JM, Bhinder G, Sham HP, Ryz N, Huang T, Bergstrom KS, Vallance BA.

Infect Immun. 2013 Dec;81(12):4649-58. doi: 10.1128/IAI.00655-13. Epub 2013 Oct 7.

16.

Interleukin-1 receptor signaling protects mice from lethal intestinal damage caused by the attaching and effacing pathogen Citrobacter rodentium.

Lebeis SL, Powell KR, Merlin D, Sherman MA, Kalman D.

Infect Immun. 2009 Feb;77(2):604-14. doi: 10.1128/IAI.00907-08. Epub 2008 Dec 15.

17.

Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors.

Wu X, Vallance BA, Boyer L, Bergstrom KS, Walker J, Madsen K, O'Kusky JR, Buchan AM, Jacobson K.

Am J Physiol Gastrointest Liver Physiol. 2008 Jan;294(1):G295-306. Epub 2007 Nov 21.

18.

Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice.

Sokol H, Conway KL, Zhang M, Choi M, Morin B, Cao Z, Villablanca EJ, Li C, Wijmenga C, Yun SH, Shi HN, Xavier RJ.

Gastroenterology. 2013 Sep;145(3):591-601.e3. doi: 10.1053/j.gastro.2013.05.047. Epub 2013 May 31.

19.

Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis.

Conlin VS, Wu X, Nguyen C, Dai C, Vallance BA, Buchan AM, Boyer L, Jacobson K.

Am J Physiol Gastrointest Liver Physiol. 2009 Oct;297(4):G735-50. doi: 10.1152/ajpgi.90551.2008. Epub 2009 Aug 6.

20.

Probiotic Lactobacillus reuteri attenuates the stressor-enhanced severity of Citrobacter rodentium infection.

Mackos AR, Eubank TD, Parry NM, Bailey MT.

Infect Immun. 2013 Sep;81(9):3253-63. doi: 10.1128/IAI.00278-13. Epub 2013 Jun 24.

Supplemental Content

Support Center